パートグラム情報の提示が産科の意思決定に与える影響
1University Department of Obstetrics and Gynaecology, St James' Hospital, Leeds, UK.
Lancet (London, England)
|June 20, 1992
まとめ
パートグラムでの出産データの視覚的な表示は,産婦人科医に大きな影響を与えます.
科学分野:
- 産婦人科と産婦人科を担当しています.
- 医療の意思決定について
- クリニカル・インフォマティックス
背景:
- 医療情報のプレゼンテーションは,臨床的意思決定に影響を及ぼします.
- パートグラムは,出産の進行を監視するための重要なツールです.
- パートグラムの表示の変動は,産科介入に影響を与える可能性があります.
研究 の 目的:
- パートグラムの視覚的外観の変更が分娩中の産婦人科医の臨床決定に影響を与えるかどうかを評価する.
- パートグラムスケールと潜伏期の含有が介入率に与える影響を調査する.
主な方法:
- 16人の初級産婦人科医に,6つの仮説的な難産症例が提示されました.
- パートグラムの外観は,x-y軸のスケールを操作し,潜伏期を含み,多様でした.
- 産婦人科の経営決定と介入の可能性を記録した.
主要な成果:
- 医者は,出産の進行曲線が平らになったときに積極的に介入する傾向がありました.
- 潜伏期をパートグラムに含めると,介入の可能性も高まった.
- パートグラムのグラフィック表現 (形状,起源) は,介入率に影響を与える可能性があります.
結論:
- パートグラムの視覚的なデザインは,産科介入の決定において重要な役割を果たします.
- パートグラムの提示は,病院間の帝王切開率の変動を部分的に説明する可能性があります.
- パートグラムのビジュアライゼーションを最適化することで,労働管理を標準化し,不要な介入を減らすことができます.
関連する概念動画
Methods of Documentation III: PIE
Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Fetal Circulation
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...


